Benzinga | Jan 12, 2022 09:05AM EST

Dawson James Initiates Coverage On Bluejay Diagnostics with Buy Rating, Announces Price Target of $10

Dawson James analyst Jason Kolbert initiates coverage on Bluejay Diagnostics (NASDAQ:BJDX) with a Buy rating and announces Price Target of $10.